Tourmaline Bio, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €51.64M +1,223.2% -€193.98M +0.3% -375.6% +46 pp N/A N/A
    (estimated) €3.90M -72.8% -€193.35M +25.7% -4,954.1% -39 pp N/A N/A
    (estimated) €14.36M +∞% -€153.86M +47.2% -1,071.3% -11 pp N/A N/A
    (estimated) €0.00 +NaN% -€104.49M +23.9% N/A N/A N/A
    (estimated) €0.00 +NaN% -€84.33M +33.7% N/A N/A N/A
    €0.00 +NaN% -€63.07M +6.5% N/A -€66.56M +33.6% N/A
    €0.00 +NaN% -€59.21M +42.7% N/A -€49.81M +54.0% N/A
    €0.00 +NaN% -€41.49M +111.9% N/A -€32.35M +109.5% N/A
    €0.00 +NaN% -€19.58M +26.8% N/A -€15.44M +4.8% N/A
    €0.00 -€15.45M N/A -€14.73M N/A

    Notifications